+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Application - Forecast 2024-2030- Product Image
Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Application - Forecast 2024-2030- Product Image
Sale

Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985926
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tumor Ablation Market size was estimated at USD 1.11 billion in 2023, USD 1.33 billion in 2024, and is expected to grow at a CAGR of 19.67% to reach USD 3.91 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tumor Ablation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tumor Ablation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tumor Ablation Market, highlighting leading vendors and their innovative profiles. These include Angiodynamics, Inc., Bioventus LLC., Boston Scientific Corp., BVM Medical Limited, Chongqing Haifu Medical Technology Co., Ltd., CONMED Corporation, CooperSurgical, Inc., Erbe Elektromedizin GmbH, IceCure Medical Ltd., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Mermaid Medical A / S, Smith & Nephew PLC, and Theraclion S. A.

Market Segmentation & Coverage

This research report categorizes the Tumor Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Cryoablation
    • High-Intensity Focused Ultrasound
    • Laser Interstitial Thermal Ablation
    • Microwave Ablation
    • Radiofrequency Ablation
  • Treatment
    • Laparoscopic Ablation
    • Percutaneous Ablation
    • Surgical Ablation
  • Application
    • Bone Metastasis
    • Kidney Cancer
    • Liver Cancer
    • Lung Cancer
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Tumor Ablation Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tumor Ablation Market?
  3. What are the technology trends and regulatory frameworks in the Tumor Ablation Market?
  4. What is the market share of the leading vendors in the Tumor Ablation Market?
  5. Which modes and strategic moves are suitable for entering the Tumor Ablation Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Tumor Ablation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Globally growing geriatric population
5.1.1.2. Growing awareness about ablation procedures over conventional therapeutic and surgical procedures
5.1.1.3. Increasing prevalence and indication of cancer
5.1.1.4. Technological advancements in ablation devices
5.1.2. Restraints
5.1.2.1. String regulatory guidelines by governments
5.1.3. Opportunities
5.1.3.1. Potential prospects in emerging markets
5.1.3.2. Collaborative Product development
5.1.4. Challenges
5.1.4.1. Cost containment measures taken by various government
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Tumor Ablation Market, by Technology
6.1. Introduction
6.2. Cryoablation
6.3. High-Intensity Focused Ultrasound
6.4. Laser Interstitial Thermal Ablation
6.5. Microwave Ablation
6.6. Radiofrequency Ablation
7. Tumor Ablation Market, by Treatment
7.1. Introduction
7.2. Laparoscopic Ablation
7.3. Percutaneous Ablation
7.4. Surgical Ablation
8. Tumor Ablation Market, by Application
8.1. Introduction
8.2. Bone Metastasis
8.3. Kidney Cancer
8.4. Liver Cancer
8.5. Lung Cancer
9. Americas Tumor Ablation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Tumor Ablation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Tumor Ablation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Angiodynamics, Inc.
13.1.2. Bioventus LLC.
13.1.3. Boston Scientific Corp.
13.1.4. BVM Medical Limited
13.1.5. Chongqing Haifu Medical Technology Co., Ltd.
13.1.6. CONMED Corporation
13.1.7. CooperSurgical, Inc.
13.1.8. Erbe Elektromedizin GmbH
13.1.9. IceCure Medical Ltd.
13.1.10. Integra LifeSciences Corporation
13.1.11. Johnson & Johnson Services, Inc.
13.1.12. Medtronic PLC
13.1.13. Mermaid Medical A / S
13.1.14. Smith & Nephew PLC
13.1.15. Theraclion S. A.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. TUMOR ABLATION MARKET RESEARCH PROCESS
FIGURE 2. TUMOR ABLATION MARKET SIZE, 2023 VS 2030
FIGURE 3. TUMOR ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TUMOR ABLATION MARKET DYNAMICS
FIGURE 7. TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. TUMOR ABLATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TUMOR ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 12. TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. TUMOR ABLATION MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. CANADA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. CANADA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. MEXICO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. MEXICO TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. CHINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. CHINA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. INDIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. INDIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. JAPAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. JAPAN TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. THAILAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. THAILAND TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. DENMARK TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. EGYPT TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. EGYPT TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. FINLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. FINLAND TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. FRANCE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. GERMANY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. ITALY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. ITALY TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. NORWAY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. NORWAY TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. POLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. POLAND TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. QATAR TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. QATAR TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. SPAIN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. SPAIN TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. TURKEY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. TURKEY TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 148. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. TUMOR ABLATION MARKET LICENSE & PRICING

Companies Mentioned

  • Angiodynamics, Inc.
  • Bioventus LLC.
  • Boston Scientific Corp.
  • BVM Medical Limited
  • Chongqing Haifu Medical Technology Co., Ltd.
  • CONMED Corporation
  • CooperSurgical, Inc.
  • Erbe Elektromedizin GmbH
  • IceCure Medical Ltd.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Mermaid Medical A / S
  • Smith & Nephew PLC
  • Theraclion S. A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.33 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.91 Billion
Compound Annual Growth Rate19.6%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Tumor Ablation Market Size, Share & Trends Analysis Report by Technology (Microwave, HIFU), Treatment (Laparoscopic Ablation, Percutaneous Ablation), Application (Liver Cancer, Lung Cancer), and Segment Forecasts, 2024-2030 - Product Image

Global Tumor Ablation Market Size, Share & Trends Analysis Report by Technology (Microwave, HIFU), Treatment (Laparoscopic Ablation, Percutaneous Ablation), Application (Liver Cancer, Lung Cancer), and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Tumor Ablation Market Report by Technology, Mode of Treatment, Mode of Application, End-User, and Region 2024-2032 - Product Image

Tumor Ablation Market Report by Technology, Mode of Treatment, Mode of Application, End-User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Tumor Ablation Therapy Devices Global Market Report 2024 - Product Image

Tumor Ablation Therapy Devices Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Tumor Ablation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Tumor Ablation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Tumor Ablation Technologies - Global Strategic Business Report - Product Image

Tumor Ablation Technologies - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Tumor Ablation Market

Tumor Ablation is a minimally invasive surgical procedure used to treat tumors. It involves the use of heat, cold, or other energy sources to destroy cancerous cells. The procedure is typically performed using a needle, probe, or catheter inserted into the tumor. It is often used to treat tumors that are too small or too deep to be removed surgically. It can also be used to treat tumors that have spread to other parts of the body. Tumor Ablation is a relatively new procedure and is becoming increasingly popular due to its minimally invasive nature and its ability to treat tumors that are difficult to remove surgically. It is also a cost-effective alternative to more traditional treatments such as chemotherapy and radiation. Some of the companies in the Tumor Ablation market include AngioDynamics, Medtronic, Boston Scientific, and Stryker. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.